Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population.

[1]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[2]  M. Mack,et al.  Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial , 2019, Circulation.

[3]  H. Wijeysundera,et al.  Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients. , 2018, The Annals of thoracic surgery.

[4]  E. Tuzcu,et al.  Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. , 2018, JACC. Cardiovascular interventions.

[5]  P. Coyte,et al.  A cost‐utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk , 2018, The Journal of thoracic and cardiovascular surgery.

[6]  Deepak L. Bhatt,et al.  Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial. , 2017, Diabetes research and clinical practice.

[7]  J. Zamorano,et al.  SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve , 2017, European heart journal.

[8]  C. Anderson,et al.  Risk‐adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR) , 2017, The Medical journal of Australia.

[9]  S. Jan,et al.  Economic evaluation of medicines. , 2017, Australian prescriber.

[10]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[11]  R. Lange,et al.  Quality of Life After Transcatheter Aortic Valve Replacement: Prospective Data From GARY (German Aortic Valve Registry). , 2016, JACC. Cardiovascular interventions.

[12]  Dimitris Mavridis,et al.  Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. , 2016, European heart journal.

[13]  W. Vach,et al.  Quality of life among elderly patients undergoing transcatheter or surgical aortic valve replacement– a model-based longitudinal data analysis , 2016, Health and Quality of Life Outcomes.

[14]  J. Leipsic,et al.  Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. , 2016, European heart journal.

[15]  J. Coselli,et al.  3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. , 2016, Journal of the American College of Cardiology.

[16]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[17]  D. Gauci,et al.  Does Aortic Valve Replacement Restore Normal Life Expectancy: a Twenty-Year Relative Survival Study , 2016 .

[18]  D. Wood,et al.  Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay , 2016, Circulation. Cardiovascular quality and outcomes.

[19]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[20]  J. Carroll,et al.  Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2015, Journal of the American College of Cardiology.

[21]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[22]  D. Capodanno,et al.  Early discharge after transfemoral transcatheter aortic valve implantation , 2015, Heart.

[23]  A. Cribier,et al.  Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. , 2015, The American journal of cardiology.

[24]  J. Leipsic,et al.  Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. , 2014, Journal of the American College of Cardiology.

[25]  A. Thrift,et al.  Long-Term Costs of Stroke Using 10-Year Longitudinal Data From the North East Melbourne Stroke Incidence Study , 2014, Stroke.

[26]  R. Goeree,et al.  Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. , 2013, The Journal of thoracic and cardiovascular surgery.

[27]  S. Plein,et al.  The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk , 2013, Heart.

[28]  A. Bogers,et al.  Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. , 2012, The Annals of thoracic surgery.

[29]  M. Neyt,et al.  A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population , 2012, BMJ Open.

[30]  T. Marwick,et al.  Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model. , 2012, Annals of cardiothoracic surgery.

[31]  C. Marini,et al.  Stroke in the Very Old: A Systematic Review of Studies on Incidence, Outcome, and Resource Use , 2011, Journal of aging research.

[32]  B. Carabello.  Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.

[33]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[34]  Geoffrey A. Donnan,et al.  Quality of Life After Stroke: The North East Melbourne Stroke Incidence Study (NEMESIS) , 2004, Stroke.

[35]  Ralph B D'Agostino,et al.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. , 2003, JAMA.

[36]  C. Anderson,et al.  Ten-Year Survival After First-Ever Stroke in the Perth Community Stroke Study , 2003, Stroke.

[37]  J. Heikkilä,et al.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.

[38]  O. Hess,et al.  Spontaneous course of aortic valve disease. , 1987, European heart journal.

[39]  P. Jansz,et al.  Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year. , 2014, International journal of cardiology.

[40]  J. Spertus,et al.  Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.